Skip to main content
. 2023 Sep 30;12(19):6311. doi: 10.3390/jcm12196311

Figure 2.

Figure 2

Figure 2

Figure 2

Forest plots representing the pooled prevalence of (A) improved, (B) stable, and (C) worsened patients with multiple sclerosis following mesenchymal stem cell therapy.